ClinVar Miner

Submissions for variant NM_152641.4(ARID2):c.1121-1G>A

dbSNP: rs1943242602
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 1
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Rady Children's Institute for Genomic Medicine, Rady Children's Hospital San Diego RCV001265602 SCV001443770 pathogenic Coffin-Siris syndrome 6 2020-03-27 criteria provided, single submitter clinical testing This variant affects the canonical splice acceptor site of intron 9 and is therefore predicted to interfere with splicing and result in loss of normal protein function. This variant has not been previously reported or functionally characterized in the literature to our knowledge. It is absent from the gnomAD population database and thus is presumed to be rare. Multiple splice prediction tools suggest this variant is likely to interfere with normal splicing. The ARID2 gene is highly intolerant of loss-of-function variants (pLI of 1) and the majority of disease causing ARID2 variations reported are de novo loss-of-function variants (PMID: 28124119, 26238514). Analysis of the parental samples was negative for the variant, indicating this variant likely occurred as a de novo event. Based on the available evidence, the c.1121-1G>A variant is classified as Pathogenic.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.